Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa inthe intensive care unit setting

Infection Control and Hospital Epidemiology

Volumn 32, Issue 7, 2011, Pages 719-722

  Harris, Anthony D ^a,b   Johnson, J Kristie ^a   Thom, Kerri A ^a,b   Morgan, Daniel J ^a,b   McGregor, Jessina C ^c   Ajao, Adebola O ^a   Moore, Anita C ^a   Comer, Angela C ^a   Furuno, Jon P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; PSEUDOMONAS INFECTION; RISK FACTOR;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; COHORT STUDIES; CROSS INFECTION; FEMALE; HUMANS; IMIPENEM; INTENSIVE CARE UNITS; INTESTINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS;

EID: 79958735301     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/660763     Document Type: Article

References (10)

1. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update:antimicrobial-resistant pathogens associated with healthcareassociatedinfections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol2008;29:996-1011.
2. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonizationpressure" in the spread of vancomycin-resistant enterococci:an important infection control variable. Arch InternMed 1998;158:1127-1132.
3. Lepelletier D, Caroff N, Riochet D, et al. Role of hospital stayand antibiotic use on Pseudomonas aeruginosa gastrointestinalcolonization in hospitalized patients. Eur J Clin Microbiol Infect Dis 2006;25:600-603.
4. Pena C, Guzman A, Suarez C, et al. Effects of carbapenemexposure on the risk for digestive tract carriage of intensive careunit-endemic carbapenem-resistant Pseudomonas aeruginosastrains in critically ill patients. Antimicrob Agents Chemother 2007;51:1967-1971.
5. Johnson JK, Smith G, Lee MS, et al. The role of patient-topatient transmission in the acquisition of imipenem-resistantPseudomonas aeruginosa colonization in the intensive care unit. J Infect Dis 2009;200:900-905.
6. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodologicalprinciples of case-control studies that analyzed risk factorsfor antibiotic resistance: a systematic review. Clin Infect Dis 2001;32:1055-1061.
7. Lankford MG, Collins S, Youngberg L, Rooney DM, Warren JR, Noskin GA. Assessment of materials commonly utilized inhealth care: implications for bacterial survival and transmission. Am J Infect Control 2006;34:258-263.
8. Panagea S, Winstanley C, Walshaw MJ, Ledson MJ, Hart CA.Environmental contamination with an epidemic strain of Pseudomonasaeruginosa in a Liverpool cystic fibrosis centre, andstudy of its survival on dry surfaces. J Hosp Infect 2005;59:102-107.
9. Kollef MH. Broad-spectrum antimicrobials and the treatmentof serious bacterial infections: getting it right up front. Clin InfectDis 2008;47(suppl 1):S3-S13.
10. Thom KA, Johnson JA, Strauss SM, Furuno JP, Perencevich EN,Harris AD. Increasing prevalence of gastrointestinal colonizationwith ceftazidime-resistant gram-negative bacteria among intensivecare unit patients. Infect Control Hosp Epidemiol 2007;28:1240-1246.